NKBio files patent application for new atherosclerosis treatment

Published: 2008-07-30 06:31:00
Updated: 2008-07-30 06:31:00
NKBio says it has filed its domestic patent application for cytokeratin-1 compound, a potential drug candidate in the prevention and treatment of atherosclerosis.

The company notes that cytokeratin-1, which is associated with atherosclerosis in the body, will pave the way to clarify the etiolo...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.